Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$799M |
| 2 |
Tesla
TSLA
|
+$295M |
| 3 |
PPG Industries
PPG
|
+$256M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$256M |
| 5 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.11B |
| 2 |
Amazon
AMZN
|
+$1.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 5 |
Apple
AAPL
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.3% |
| 2 | Healthcare | 8.05% |
| 3 | Financials | 7.53% |
| 4 | Consumer Discretionary | 6.73% |
| 5 | Industrials | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
4851
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $296K | ﹤0.01% |
30,307
-38,715
| -56% | -$728K |
|
|
BASE
4852
DELISTED
Couchbase
BASE
| $295K | ﹤0.01% |
11,812
+11,744
| +17,271% | +$388K |
|
4853
Invesco BulletShares 2027 High Yield Corporate Bond ETF
BSJR
$882M
| $295K | ﹤0.01% |
11,637
+7,922
| +213% | +$201K |
|
4854
PUT
Exelon
EXC
$46.2B
| $295K | ﹤0.01% |
7,150
-10,235
| -59% | -$385K |
|
|
BHR
4855
Braemar Hotels & Resorts
BHR
$138M
| $294K | ﹤0.01% |
57,614
+57,260
| +16,175% | +$281K |
|
4856
CALL
Dillards
DDS
$10.1B
| $294K | ﹤0.01% |
+1,200
| New | +$316K |
|
4857
iShares MSCI Intl Quality Factor ETF
IQLT
$14.2B
| $293K | ﹤0.01% |
7,436
+4,825
| +185% | +$189K |
|
4858
Stoneridge
SRI
$193M
| $293K | ﹤0.01% |
14,870
+10,541
| +243% | +$223K |
|
|
CRT
4859
Cross Timbers Royalty Trust
CRT
$59.8M
| $292K | ﹤0.01% |
25,503
-43,698
| -63% | -$563K |
|
4860
Greif Class B
GEF.B
$4.23B
| $292K | ﹤0.01% |
4,881
+4,003
| +456% | +$257K |
|
4861
Ocular Therapeutix
OCUL
$2.14B
| $292K | ﹤0.01% |
42,036
-14,450
| -26% | -$112K |
|
4862
Farmers & Merchants Bancorp
FMAO
$483M
| $291K | ﹤0.01% |
8,873
+8,811
| +14,211% | +$240K |
|
4863
Ribbon Communications
RBBN
$356M
| $291K | ﹤0.01% |
48,132
+45,561
| +1,772% | +$270K |
|
4864
Rayonier Advanced Materials
RYAM
$590M
| $291K | ﹤0.01% |
51,063
+572
| +1% | +$3.72K |
|
4865
Valhi
VHI
$463M
| $289K | ﹤0.01% |
10,064
-9,160
| -48% | -$234K |
|
4866
Westlake Chemical Partners
WLKP
$760M
| $289K | ﹤0.01% |
10,762
-159
| -1% | -$3.94K |
|
|
GNT
4867
GAMCO Natural Resources, Gold & Income Trust
GNT
$149M
| $288K | ﹤0.01% |
53,751
+16,051
| +43% | +$84.9K |
|
|
ICAD
4868
DELISTED
iCAD Inc
ICAD
| $287K | ﹤0.01% |
39,718
+13,198
| +50% | +$118K |
|
4869
908 Devices
MASS
$414M
| $287K | ﹤0.01% |
11,092
+10,483
| +1,721% | +$308K |
|
|
KALV
4870
DELISTED
KalVista Pharmaceuticals
KALV
| $284K | ﹤0.01% |
21,509
-58,687
| -73% | -$934K |
|
4871
CALL
Lockheed Martin
LMT
$138B
| $284K | ﹤0.01% |
+800
| New | +$277K |
|
4872
Invesco Bloomberg Pricing Power ETF
POWA
$184M
| $284K | ﹤0.01% |
3,886
-45
| -1% | -$3.14K |
|
4873
Blue Ridge Bankshares
BRBS
$335M
| $282K | ﹤0.01% |
15,752
+14,025
| +812% | +$255K |
|
4874
Ultragenyx Pharmaceutical
RARE
$2.66B
| $282K | ﹤0.01% |
3,352
-2,196
| -40% | -$179K |
|
|
KDNY
4875
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $282K | ﹤0.01% |
17,263
-36,860
| -68% | -$525K |
|
Similar funds
Wells Fargo's Q4 2021 Portfolio in Review
As of Q4 2021, Wells Fargo held 8,381 positions worth $401B, down 12% from $455B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wells Fargo withdrew a net $88.2B in Q4 2021, closing 389 positions and reducing 3,415 holdings. Its most notable exit was Kansas City Southern, an estimated $61.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wells Fargo opened a new position in Bank of America Series L worth $44.7M.
- Wells Fargo's largest Q4 2021 buy was Bank of America Series L: 30,939 shares worth $44.7M.
- Wells Fargo added most to Vanguard Morningstar Mid-Cap ETF in Q4 2021, an estimated $799M increase.
- Wells Fargo's biggest Q4 2021 reduction was Microsoft, cutting an estimated $3.11B.
- Wells Fargo fully exited Kansas City Southern in Q4 2021, selling an estimated $61.9M.
- Wells Fargo's ten largest holdings make up 18% of its $401B portfolio in Q4 2021.
- Wells Fargo opened 685 new positions and closed 389 in Q4 2021.
- Wells Fargo's portfolio value fell 12% quarter-over-quarter to $401B.
Based on Wells Fargo's 13F filing for Q4 2021, filed 14 Feb 2022.